These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 16841955)
21. Cytochrome p450 and chemical toxicology. Guengerich FP Chem Res Toxicol; 2008 Jan; 21(1):70-83. PubMed ID: 18052394 [TBL] [Abstract][Full Text] [Related]
22. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
23. Applying computational modeling to drug discovery and development. Kumar N; Hendriks BS; Janes KA; de Graaf D; Lauffenburger DA Drug Discov Today; 2006 Sep; 11(17-18):806-11. PubMed ID: 16935748 [TBL] [Abstract][Full Text] [Related]
24. Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential. Xu JJ; Diaz D; O'Brien PJ Chem Biol Interact; 2004 Nov; 150(1):115-28. PubMed ID: 15522265 [TBL] [Abstract][Full Text] [Related]
25. Recent advances in applications of liquid chromatography-tandem mass spectrometry to the analysis of reactive drug metabolites. Ma S; Zhu M Chem Biol Interact; 2009 Apr; 179(1):25-37. PubMed ID: 18848531 [TBL] [Abstract][Full Text] [Related]
26. In silico toxicology for the pharmaceutical sciences. Valerio LG Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836 [TBL] [Abstract][Full Text] [Related]
27. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. Baillie TA Chem Res Toxicol; 2008 Jan; 21(1):129-37. PubMed ID: 18052111 [TBL] [Abstract][Full Text] [Related]
28. Emerging fundamental roles for non-coding RNA species in toxicology. Taylor EL; Gant TW Toxicology; 2008 Apr; 246(1):34-9. PubMed ID: 18289762 [TBL] [Abstract][Full Text] [Related]
29. Biomarkers in aquatic plants: selection and utility. Brain RA; Cedergreen N Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039 [TBL] [Abstract][Full Text] [Related]
30. Metabolites in safety testing: metabolite identification strategies in discovery and development. Nedderman AN Biopharm Drug Dispos; 2009 May; 30(4):153-62. PubMed ID: 19544286 [TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of reactive metabolites in natural products-driven drug discovery. Njuguna NM; Masimirembwa C; Chibale K J Nat Prod; 2012 Mar; 75(3):507-13. PubMed ID: 22296642 [TBL] [Abstract][Full Text] [Related]
32. Strategy for genotoxicity testing--metabolic considerations. Ku WW; Bigger A; Brambilla G; Glatt H; Gocke E; Guzzie PJ; Hakura A; Honma M; Martus HJ; Obach RS; Roberts S; Mutat Res; 2007 Feb; 627(1):59-77. PubMed ID: 17141553 [TBL] [Abstract][Full Text] [Related]
33. Chemical toxicology of reactive intermediates formed by the glutathione-dependent bioactivation of halogen-containing compounds. Anders MW Chem Res Toxicol; 2008 Jan; 21(1):145-59. PubMed ID: 17696489 [TBL] [Abstract][Full Text] [Related]
34. Importance of molecular computer modeling in anticancer drug development. Geromichalos GD J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268 [TBL] [Abstract][Full Text] [Related]
35. Minimising the potential for metabolic activation in drug discovery. Kalgutkar AS; Soglia JR Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):91-142. PubMed ID: 16922655 [TBL] [Abstract][Full Text] [Related]
36. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery. Prestwich GD Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274 [TBL] [Abstract][Full Text] [Related]
37. Future of toxicology--predictive toxicology: An expanded view of "chemical toxicity". Richard AM Chem Res Toxicol; 2006 Oct; 19(10):1257-62. PubMed ID: 17040094 [TBL] [Abstract][Full Text] [Related]
38. Future of toxicology--low-dose toxicology and risk--benefit analysis. Rietjens IM; Alink GM Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235 [TBL] [Abstract][Full Text] [Related]
39. Understanding mechanisms of toxicity: insights from drug discovery research. Houck KA; Kavlock RJ Toxicol Appl Pharmacol; 2008 Mar; 227(2):163-78. PubMed ID: 18063003 [TBL] [Abstract][Full Text] [Related]
40. Metabolites and safety: What are the concerns, and how should we address them? Smith DA; Obach RS Chem Res Toxicol; 2006 Dec; 19(12):1570-9. PubMed ID: 17173370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]